pre-miRNA Information | |
---|---|
pre-miRNA | hsa-mir-4260 |
Genomic Coordinates | chr1: 209623444 - 209623510 |
Description | Homo sapiens miR-4260 stem-loop |
Comment | None |
RNA Secondary Structure |
Mature miRNA Information | |||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mature miRNA | hsa-miR-4260 | ||||||||||||
Sequence | 11| CUUGGGGCAUGGAGUCCCA |29 | ||||||||||||
Evidence | Experimental | ||||||||||||
Experiments | SOLiD | DRVs in miRNA |
|
||||||||||
SNPs in miRNA |
|
||||||||||||
Putative Targets |
miRNA Expression profile | |
---|---|
Human miRNA Tissue Atlas | |
Circulating MicroRNA Expression Profiling |
Gene Information | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gene Symbol | ELOVL5 | ||||||||||||||||||||
Synonyms | HELO1, SCA38, dJ483K16.1 | ||||||||||||||||||||
Description | ELOVL fatty acid elongase 5 | ||||||||||||||||||||
Transcript | NM_021814 | ||||||||||||||||||||
Expression | |||||||||||||||||||||
Putative miRNA Targets on ELOVL5 | |||||||||||||||||||||
3'UTR of ELOVL5 (miRNA target sites are highlighted) |
>ELOVL5|NM_021814|3'UTR 1 AGTCAAAGAATTGAAACCCTCCAAACCACGTCATCTGATTGTAAGCACAATATGAGTTGTGCCCCAATGCTCGTTAACAG 81 CTGCTGTAACTAGTCTGGCCTACAATAGTGTGATTCATGTAGGACTTCTTTCATCAATTCAAAACCCCTAGAAAACGTAT 161 ACAGATTATATAAGTAGGGATAAGATTTCTAACATTTCTGGGCTCTCTGACCCCTGCGCTAGACTGTGGAAAGGGAGTAT 241 TATTATAGTATACAACACTGCTGTTGCCTTATTAGTTATAACATGATAGGTGCTGAATTGTGATTCACAATTTAAAAACA 321 CTGTAATCCAAACTTTTTTTTTTAACTGTAGATCATGCATGTGATTGTAAATGTAAATTTGTACAATGTTGTTATGGTAG 401 AGAAACACACATGCCTTAAAATTTAAAAAGCAGGGCCCAAAGCTTATTAGTTTAAATTAGGGTATGTTTCAAGTTTGTAT 481 TAATTTGTAATAGCTCTGTTTAGAAAAAATCAAAGACCATGATTTATGAAACTAATGTGACATAATTTCCAGTGACTTGT 561 TGATGTGAAATCAGACACGGCACCTTCAGTTTTGTACTATTGGCTTTGAATCAAGCAGGCTCAAATCTAGTGGAACAGTC 641 AGTTTAACTTTTTAACAGATCTTATTTTTTTATTTTGAGTGCCACTATTAATGTAAAAAGGGGGGGGCTCTACAGCAGTC 721 GTGATGAAACTTAAATATATATTCTTTGTCCTCGAGATTTTAGGAAGGGTGTAGGGTGAGTAGGCCATTTTTAATTTCTG 801 AAGTGCTAAGTGTTTTTATACAGCAAACAAAAAGTCAATTTTGCTTTCCACCAGTGCGAGAGAGGATGTATACTTTTCAA 881 GAGAGATGATTGCCTATTTACCGTTTGACAGAGTCCCGTAGATGAGCAATGGGGAACTGGTTGCCAGGGTCTAAATTTGG 961 ATTGATTTATGCACTGTTATCTGTTTTGACACAGATTTCCTTGTAAAATGTGCCTAGTTTACCAAAATTAACAAAGGGGG 1041 GGAAAGGACCTTAGAACTTTTTAAGGTAAAATCAAATATAGCTACAGCATAAGAGAATCGAGAAATTTGATAGAGGTAAC 1121 TTGTTTAATGTAAATCTAATAGTACTTGTAATTTCTTTCTGCTTAGAATCTAAAGATGTGTTTAGAACCTCTTGTTTAAA 1201 AATAATAGACTGCTTATCATAAAATCACATCTCACACATTTGAGGCAGTGGTCAAACAGGTAAAGCCTATGATGTGTGTC 1281 ATTTTAAAGTGTCGGAATTTAGCCTCTGAATACCTTCTCCATTGGGGGAAAGATATTCTTGGAACCACTCATGACATATC 1361 TTAGAAGGTCATTGACAATGTATAAACTAATTGTTGGTTTGATATTTATGTAAATATCAGTTTACCATGCTTTAATTTTG 1441 CACATTCGTACTATAGGGAGCCTATTGGTTCTCTATTAGTCTTGTGGGTTTTCTGTTTGAAAAGGAGTCATGGCATCTGT 1521 TTACATTTACCTTATCAAACCTAGAATGTGTATATTTATAAATGTATGTCTTCATTGCTAGGTACTAATTTGCAGATGTC 1601 TTTACATATTTCAATACAGAAACTATAACATTCAATAGTGTGCTGTCAAAGTGTGCTTAGCTCACCTGGATATACCTACA 1681 TTGTTAAATGTCTAAACAGTAATCATTAAAACATTTTTGATTACCTGTGAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA 1761 AAAAAAA Target sites
Provided by authors
Predicted by miRanda
DRVs
SNPs
DRVs & SNPs
|
||||||||||||||||||||
miRNA-target interactions (Predicted by miRanda) |
|
||||||||||||||||||||
DRVs in gene 3'UTRs | |||||||||||||||||||||
SNPs in gene 3'UTRs |
Experimental Support 1 for Functional miRNA-Target Interaction | |||||||
---|---|---|---|---|---|---|---|
miRNA:Target | ---- | ||||||
Validation Method |
|
||||||
Conditions | TZM-bl | ||||||
Location of target site | 3'UTR | ||||||
Tools used in this research | TargetScan , miRTarCLIP , Piranha | ||||||
Original Description (Extracted from the article) |
...
PAR-CLIP data was present in GSM1462574. RNA binding protein: AGO2. Condition:TZM-bl ami BaL
... - Whisnant AW; Bogerd HP; Flores O; Ho P; et al., 2013, mBio. |
||||||
miRNA-target interactions (Provided by authors) |
|
||||||
Article |
- Whisnant AW; Bogerd HP; Flores O; Ho P; et al. - mBio, 2013
UNLABELLED: The question of how HIV-1 interfaces with cellular microRNA (miRNA) biogenesis and effector mechanisms has been highly controversial. Here, we first used deep sequencing of small RNAs present in two different infected cell lines (TZM-bl and C8166) and two types of primary human cells (CD4(+) peripheral blood mononuclear cells [PBMCs] and macrophages) to unequivocally demonstrate that HIV-1 does not encode any viral miRNAs. Perhaps surprisingly, we also observed that infection of T cells by HIV-1 has only a modest effect on the expression of cellular miRNAs at early times after infection. Comprehensive analysis of miRNA binding to the HIV-1 genome using the photoactivatable ribonucleoside-induced cross-linking and immunoprecipitation (PAR-CLIP) technique revealed several binding sites for cellular miRNAs, a subset of which were shown to be capable of mediating miRNA-mediated repression of gene expression. However, the main finding from this analysis is that HIV-1 transcripts are largely refractory to miRNA binding, most probably due to extensive viral RNA secondary structure. Together, these data demonstrate that HIV-1 neither encodes viral miRNAs nor strongly influences cellular miRNA expression, at least early after infection, and imply that HIV-1 transcripts have evolved to avoid inhibition by preexisting cellular miRNAs by adopting extensive RNA secondary structures that occlude most potential miRNA binding sites. IMPORTANCE: MicroRNAs (miRNAs) are a ubiquitous class of small regulatory RNAs that serve as posttranscriptional regulators of gene expression. Previous work has suggested that HIV-1 might subvert the function of the cellular miRNA machinery by expressing viral miRNAs or by dramatically altering the level of cellular miRNA expression. Using very sensitive approaches, we now demonstrate that neither of these ideas is in fact correct. Moreover, HIV-1 transcripts appear to largely avoid regulation by cellular miRNAs by adopting an extensive RNA secondary structure that occludes the ability of cellular miRNAs to interact with viral mRNAs. Together, these data suggest that HIV-1, rather than seeking to control miRNA function in infected cells, has instead evolved a mechanism to become largely invisible to cellular miRNA effector mechanisms.
LinkOut: [PMID: 23592263]
|
CLIP-seq Support 1 for dataset GSM4903825 | |
---|---|
Method / RBP | HITS-CLIP / AGO |
Cell line / Condition | Dermal fibroblasts / PID14_NS |
Location of target site | NM_001242830 | 3UTR | AAUGCUCGUUAACAGCUGCUGUAACUAGUCUGGCCUACAAUA |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Accession Series | GSE161237 |
CLIP-seq Viewer | Link |
CLIP-seq Support 2 for dataset GSM4903833 | |
---|---|
Method / RBP | HITS-CLIP / AGO |
Cell line / Condition | Dermal fibroblasts / CTL_TD_21_a |
Location of target site | NM_001242830 | 3UTR | CCCUCCAAACCACGUCAUCUGAUUGUAAGCACAAUAUGAGUUGUGCCCCAAUGCUCGUUAACAGCUGCUGUAACUAGUCUGGCCUACAAUA |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Accession Series | GSE161239 |
CLIP-seq Viewer | Link |
CLIP-seq Support 3 for dataset GSM4903834 | |
---|---|
Method / RBP | HITS-CLIP / AGO |
Cell line / Condition | Dermal fibroblasts / CTL_TD_21_b |
Location of target site | NM_001242830 | 3UTR | CCUCCAAACCACGUCAUCUGAUUGUAAGCACAAUAUGAGUUGUGCCCCAAUGCUCGUUAACAGCUGCUGUAACUAGUCUGGCCUACAAUA |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Accession Series | GSE161239 |
CLIP-seq Viewer | Link |
CLIP-seq Support 4 for dataset GSM4903835 | |
---|---|
Method / RBP | HITS-CLIP / AGO |
Cell line / Condition | Dermal fibroblasts / CTL_TD_21_c |
Location of target site | NM_001242830 | 3UTR | ACCCUCCAAACCACGUCAUCUGAUUGUAAGCACAAUAUGAGUUGUGCCCCAAUGCUCGUUAACAGCUGCUGUAACUAGUCUGGCCUACAAUA |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Accession Series | GSE161239 |
CLIP-seq Viewer | Link |
CLIP-seq Support 5 for dataset GSM4903836 | |
---|---|
Method / RBP | HITS-CLIP / AGO |
Cell line / Condition | Dermal fibroblasts / 124_TD_21_a |
Location of target site | NM_001242830 | 3UTR | CCUCCAAACCACGUCAUCUGAUUGUAAGCACAAUAUGAGUUGUGCCCCAAUGCUCGUUAACAGCUGCUGUAACUAGUCUGGCCUACAAUA |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Accession Series | GSE161239 |
CLIP-seq Viewer | Link |
CLIP-seq Support 6 for dataset GSM4903837 | |
---|---|
Method / RBP | HITS-CLIP / AGO |
Cell line / Condition | Dermal fibroblasts / 124_TD_21_b |
Location of target site | NM_001242830 | 3UTR | CCCUCCAAACCACGUCAUCUGAUUGUAAGCACAAUAUGAGUUGUGCCCCAAUGCUCGUUAACAGCUGCUGUAACUAGUCUGGCCUACAAUA |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Accession Series | GSE161239 |
CLIP-seq Viewer | Link |
CLIP-seq Support 7 for dataset GSM4903838 | |
---|---|
Method / RBP | HITS-CLIP / AGO |
Cell line / Condition | Dermal fibroblasts / 124_TD_21_c |
Location of target site | NM_001242830 | 3UTR | CUCCAAACCACGUCAUCUGAUUGUAAGCACAAUAUGAGUUGUGCCCCAAUGCUCGUUAACAGCUGCUGUAACUAGUCUGGCCUACAAUA |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Accession Series | GSE161239 |
CLIP-seq Viewer | Link |
CLIP-seq Support 8 for dataset GSM1462574 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | TZM-bl / TZM-bl ami BaL |
Location of target site | ENST00000370918.4 | 3UTR | CCCCAAUGCUCGUUAACAG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 23592263 / GSE59944 |
CLIP-seq Viewer | Link |
MiRNA-Target Expression Profile | |||||||
---|---|---|---|---|---|---|---|
|
MiRNA-Target Expression Profile (TCGA) | |||||||
---|---|---|---|---|---|---|---|
|
66 hsa-miR-4260 Target Genes:
Functional analysis:
ID | Target | Description | Validation methods | |||||||||
Strong evidence | Less strong evidence | |||||||||||
MIRT074404 | TNRC6A | trinucleotide repeat containing 6A | 2 | 2 | ||||||||
MIRT289774 | PER1 | period circadian clock 1 | 2 | 2 | ||||||||
MIRT442576 | HOXD9 | homeobox D9 | 2 | 2 | ||||||||
MIRT443878 | CNKSR3 | CNKSR family member 3 | 2 | 2 | ||||||||
MIRT449080 | XPO6 | exportin 6 | 2 | 2 | ||||||||
MIRT450294 | DRAXIN | dorsal inhibitory axon guidance protein | 2 | 2 | ||||||||
MIRT461785 | FXR2 | FMR1 autosomal homolog 2 | 2 | 2 | ||||||||
MIRT463931 | WNT10B | Wnt family member 10B | 2 | 2 | ||||||||
MIRT464860 | UBB | ubiquitin B | 2 | 8 | ||||||||
MIRT467619 | SLC7A5 | solute carrier family 7 member 5 | 2 | 2 | ||||||||
MIRT469649 | RAC1 | Rac family small GTPase 1 | 2 | 2 | ||||||||
MIRT473421 | MDM4 | MDM4, p53 regulator | 2 | 2 | ||||||||
MIRT473646 | MARCKSL1 | MARCKS like 1 | 2 | 2 | ||||||||
MIRT474213 | LCOR | ligand dependent nuclear receptor corepressor | 2 | 2 | ||||||||
MIRT474335 | KMT2D | lysine methyltransferase 2D | 2 | 2 | ||||||||
MIRT474871 | KDELR1 | KDEL endoplasmic reticulum protein retention receptor 1 | 2 | 2 | ||||||||
MIRT477440 | ELOVL5 | ELOVL fatty acid elongase 5 | 2 | 2 | ||||||||
MIRT478432 | DAZAP2 | DAZ associated protein 2 | 2 | 2 | ||||||||
MIRT479851 | CCDC6 | coiled-coil domain containing 6 | 2 | 2 | ||||||||
MIRT482507 | ACTB | actin beta | 2 | 2 | ||||||||
MIRT485473 | IGF1R | insulin like growth factor 1 receptor | 2 | 8 | ||||||||
MIRT485670 | CCDC64 | BICD family like cargo adaptor 1 | 2 | 4 | ||||||||
MIRT485902 | PGPEP1 | pyroglutamyl-peptidase I | 2 | 4 | ||||||||
MIRT488143 | PRRC2B | proline rich coiled-coil 2B | 2 | 4 | ||||||||
MIRT489455 | MSC | musculin | 2 | 2 | ||||||||
MIRT509568 | HIST2H2AB | histone cluster 2 H2A family member b | 2 | 4 | ||||||||
MIRT513093 | DYNAP | dynactin associated protein | 2 | 2 | ||||||||
MIRT513256 | CALM3 | calmodulin 3 | 2 | 2 | ||||||||
MIRT514356 | UBBP4 | ubiquitin B pseudogene 4 | 2 | 6 | ||||||||
MIRT522019 | PAQR3 | progestin and adipoQ receptor family member 3 | 2 | 4 | ||||||||
MIRT523164 | HIST3H3 | histone cluster 3 H3 | 2 | 2 | ||||||||
MIRT523297 | HIST1H1B | histone cluster 1 H1 family member b | 2 | 2 | ||||||||
MIRT524782 | BAG5 | BCL2 associated athanogene 5 | 2 | 2 | ||||||||
MIRT530921 | SCIN | scinderin | 2 | 2 | ||||||||
MIRT533302 | USP44 | ubiquitin specific peptidase 44 | 2 | 2 | ||||||||
MIRT552782 | YIPF4 | Yip1 domain family member 4 | 2 | 4 | ||||||||
MIRT553981 | SRPR | SRP receptor alpha subunit | 2 | 2 | ||||||||
MIRT563126 | ZNF215 | zinc finger protein 215 | 2 | 2 | ||||||||
MIRT569025 | IL21R | interleukin 21 receptor | 2 | 2 | ||||||||
MIRT573413 | RPL18A | ribosomal protein L18a | 2 | 2 | ||||||||
MIRT574877 | Dnajc6 | DnaJ heat shock protein family (Hsp40) member C6 | 2 | 3 | ||||||||
MIRT607538 | GLI2 | GLI family zinc finger 2 | 2 | 2 | ||||||||
MIRT607682 | MAPK10 | mitogen-activated protein kinase 10 | 2 | 3 | ||||||||
MIRT623791 | GK5 | glycerol kinase 5 (putative) | 2 | 2 | ||||||||
MIRT628834 | FAM151B | family with sequence similarity 151 member B | 2 | 2 | ||||||||
MIRT635547 | LEPREL1 | prolyl 3-hydroxylase 2 | 2 | 2 | ||||||||
MIRT635698 | NMNAT2 | nicotinamide nucleotide adenylyltransferase 2 | 2 | 2 | ||||||||
MIRT635906 | ARPC1B | actin related protein 2/3 complex subunit 1B | 2 | 2 | ||||||||
MIRT649985 | MSI1 | musashi RNA binding protein 1 | 2 | 2 | ||||||||
MIRT654900 | POMGNT1 | protein O-linked mannose N-acetylglucosaminyltransferase 1 (beta 1,2-) | 2 | 2 | ||||||||
MIRT655116 | PHF7 | PHD finger protein 7 | 2 | 2 | ||||||||
MIRT658958 | DNAJC6 | DnaJ heat shock protein family (Hsp40) member C6 | 2 | 3 | ||||||||
MIRT659665 | CDC42EP4 | CDC42 effector protein 4 | 2 | 2 | ||||||||
MIRT668946 | CNBP | CCHC-type zinc finger nucleic acid binding protein | 2 | 2 | ||||||||
MIRT691164 | APOL6 | apolipoprotein L6 | 2 | 2 | ||||||||
MIRT692696 | MEAF6 | MYST/Esa1 associated factor 6 | 2 | 2 | ||||||||
MIRT693245 | HBS1L | HBS1 like translational GTPase | 2 | 2 | ||||||||
MIRT695203 | SCAMP3 | secretory carrier membrane protein 3 | 2 | 2 | ||||||||
MIRT701957 | MINK1 | misshapen like kinase 1 | 2 | 2 | ||||||||
MIRT706802 | APOL4 | apolipoprotein L4 | 2 | 2 | ||||||||
MIRT716899 | CACNB2 | calcium voltage-gated channel auxiliary subunit beta 2 | 2 | 2 | ||||||||
MIRT717632 | HLX | H2.0 like homeobox | 2 | 2 | ||||||||
MIRT719052 | ZNF281 | zinc finger protein 281 | 2 | 2 | ||||||||
MIRT722973 | GDE1 | glycerophosphodiester phosphodiesterase 1 | 2 | 2 | ||||||||
MIRT723643 | RPTN | repetin | 2 | 2 | ||||||||
MIRT734708 | NR3C2 | nuclear receptor subfamily 3 group C member 2 | 4 | 0 |
miRNA-Drug Associations | ||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
miRNA-Drug Resistance Associations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|